| Facile synthesis of sterically hindered and electron-deficient secondary amides from isocyanates. G Schäfer, C Matthey, JW Bode Angewandte Chemie (International ed. in English) 51 (36), 9173-9175, 2012 | 127 | 2012 |
| Friedel–Crafts benzylation of activated and deactivated arenes G Schäfer, JW Bode Angewandte Chemie International Edition 46 (50), 10913-10916, 2011 | 88 | 2011 |
| Planar chiral asymmetric naphthalenediimide cyclophanes: synthesis, characterization and tunable FRET properties S Gabutti, S Schaffner, M Neuburger, M Fischer, G Schäfer, M Mayor Organic & Biomolecular Chemistry 7 (16), 3222-3229, 2009 | 49 | 2009 |
| Scalable Synthesis of Trifluoromethylated Imidazo-Fused N-Heterocycles Using TFAA and Trifluoroacetamide as CF3-Reagents G Schafer, M Ahmetovic, S Abele Organic letters 19 (24), 6578-6581, 2017 | 44 | 2017 |
| Synthesis of Sterically Hindered N-Acylated Amino Acids from N-Carboxyanhydrides G Schäfer, JW Bode Organic letters 16 (5), 1526-1529, 2014 | 40 | 2014 |
| Discovery of the potent, selective, orally available CXCR7 antagonist ACT-1004-1239 S Richard-Bildstein, H Aissaoui, J Pothier, G Schafer, C Gnerre, ... Journal of Medicinal Chemistry 63 (24), 15864-15882, 2020 | 39 | 2020 |
| Eine einfache Synthese von sterisch gehinderten und elektronenarmen, sekundären Amiden aus Isocyanaten G Schäfer, C Matthey, JW Bode Angewandte Chemie 36 (124), 9307-9310, 2012 | 19 | 2012 |
| The synthesis of sterically hindered amides G Schäfer, JW Bode Chimia 68 (4), 252-252, 2014 | 18 | 2014 |
| Development of a Scalable Route for a Key Thiadiazole Building Block via Sequential Sandmeyer Bromination and Room-Temperature Suzuki–Miyaura Coupling G Schäfer, T Fleischer, M Ahmetovic, S Abele Organic Process Research & Development 24 (2), 228-234, 2020 | 15 | 2020 |
| Catalytic enantioselective fluorination R Thornbury, G Schäfer, FD Toste Modern Synthesis Processes and Reactivity of Fluorinated Compounds, 223-263, 2017 | 5 | 2017 |
| Synthesis of Unsymmetrical, gem-Disubstituted Bisamides G Schäfer, L Leu, JW Bode Heterocycles 90 (2), 1375-1386, 2015 | 5 | 2015 |
| Sandmeyer Chlorosulfonylation of (Hetero)Aromatic Amines Using DABSO as an SO2 Surrogate L Pincekova, A Merot, G Schäfer, MC Willis Organic Letters 26 (28), 5951-5955, 2024 | 4 | 2024 |
| Development of a Scalable Route for a Key Benzothiazole Building Block via a Pd-Catalyzed Migita Coupling with a Nonsmelly Thiol Surrogate G Schäfer, A Merot, T Fleischer Organic Process Research & Development 26 (12), 3373-3379, 2022 | 4 | 2022 |
| Development of a Scalable Route for a Highly Polar Heterocyclic Aminocyclopropyl Building Block G Schäfer, M Ahmetovic, T Fleischer, S Abele Organic Process Research & Development 24 (9), 1735-1742, 2020 | 4 | 2020 |
| Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases EA Meyer, AL Croxford, C Gnerre, P Kulig, MJ Murphy, EM Jacob, ... Journal of Medicinal Chemistry, 2024 | 3 | 2024 |
| Development of a Scalable, Racemic First-Generation Route for CXCR7 Antagonist ACT-1004-1239 via cis-to-trans Epimerization and Subsequent Separation of … G Schäfer, T Fleischer, M Ahmetovic, P Guerry, S Abele Organic Process Research & Development, 2024 | 3 | 2024 |
| Development of a Scalable Electrophilic Amination Protocol for the Multi-kg Production of 5-Methyl-2-pyridinesulfonamide: A Regulatory Starting Material of Endothelin Receptor … G Schäfer, T Fleischer, M Kastner, R Karge, Q Huang, BL Wu, J Tang, ... Organic Process Research & Development 27 (7), 1377-1383, 2023 | 3 | 2023 |
| Initial Route Scouting and Final Process Development for the Multi-Kg Production of 3-Fluoro-6-methoxyquinoline from p-Anisidine and 2-Fluoromalonic Acid G Schäfer, T Fleischer, N Blumer, M Udry, S Reber, I Stansfield, Y Liu, ... Organic Process Research & Development 26 (2), 347-357, 2022 | 3 | 2022 |
| Large-Scale Synthesis of LPA1-Receptor Antagonist ACT-1016-0707 R Davenport, F Masse, A Prud’homme, C Burki, P Doerrwaechter, ... Organic Process Research & Development 28 (2), 577-587, 2024 | 2 | 2024 |
| Development of a Scalable Route toward an Alkylated 1, 2, 4-Triazol, a Key Starting Material for CXCR3 Antagonist ACT-777991 R Davenport, A Prud’homme, F Masse, G Schäfer Organic Process Research & Development 27 (5), 928-937, 2023 | 2 | 2023 |
